Companies

Harmoney

harmoney.in

InferEdge builds agentic AI systems that automate research, portfolio management, and risk workflows for buy-side firms.

HQMumbai, Maharashtra, India
Employees1-50
FintechAI AgentB2B SaaS

About

Harmoney, now InferEdge, builds agentic AI systems for buy-side investment teams, wealth firms, and capital-markets organizations. Its systems automate research, portfolio management, risk, and CRM workflows across equity and fixed income, differentiating through consistent, auditable workflows rather than generic AI-generated notes.

Market

Harmoney has transitioned to InferEdge and exited its bond-trading software business; the company now competes in enterprise agentic AI infrastructure and workflow automation for buy-side investment, wealth, and capital-markets teams. InferEdge positions itself above generic financial chat interfaces by combining domain-specific agents with real-time market-data ingestion, composable skills, cited outputs, evaluation and audit controls, human checkpoints, and deployment into a fund’s existing tools and cloud environment.

Target Customers

InferEdge targets institutional buy-side investment organizations—including asset managers, hedge funds, wealth firms, and capital-markets teams—with particular evidence of deployment alongside multi-billion-dollar funds. Its primary users and buyers are investment research, portfolio-management, risk, and distribution teams seeking to automate information-heavy workflows without replacing human judgment.

At a Glance

Problem

Harmoney originally addressed the friction in India’s bond markets: limited access, transparency, and efficiency for financial institutions and wealth managers. Its central use case was electronic bond trading. However, the company’s current website says it is exiting that bond-trading software business and redirecting its resources toward agentic AI for investment teams.

The current problem is the information and workflow burden inside buy-side firms. Analysts must continuously triage news, filings, transcripts, social content, market data, and research, then determine what matters for a portfolio. InferEdge, Harmoney’s new identity, frames the economic pain as wasted analyst time and slower decisions: it claims to deliver event-to-insight ten times faster and save two hours per analyst per day by automating reading, synthesis, cross-referencing, and impact assessment without replacing investment judgment.

Product / Service

Harmoney is becoming InferEdge, a B2B agentic-AI platform for investment teams, asset managers, wealth firms, and capital-markets businesses. The product combines a customizable agent platform with an agent runtime that can automate research, portfolio management, risk monitoring, and related workflows. It continuously ingests data from news, filings, transcripts, social media, and research; deduplicates and synthesizes events; maps them to holdings, mandates, or watchlists; scores their impact; and delivers the result through tools such as Slack, email, an OMS, or a PDF brief.

The delivery model is designed to fit into an existing investment stack rather than require a full replacement. Reusable skills, APIs, open-standard integrations, controlled-environment deployment, deterministic source citations, automated evaluations, and human approval checkpoints are intended to make the system reliable and auditable in regulated workflows. The benefit is not simply a generic AI summary, but a cited explanation of what changed, which holdings may be affected, and what analysts should investigate next.

Market

The company now competes in the emerging B2B fintech and investment-technology market for agentic AI in buy-side research, portfolio monitoring, and risk management. Its adjacent competitive set includes AI-native financial-research platforms such as AlphaSense, Hebbia, and Rogo, as well as incumbent investment-data and workflow systems. The older Harmoney positioning competed more directly with Indian fixed-income platforms; Tracxn names Wint Wealth, Grip, and GoldenPi as competitors, although those companies are better understood as comparables for the bond-trading business Harmoney says it is leaving.

Harmoney is not simply a pre-revenue concept: public company data reports $5.8 million raised across three rounds, Y Combinator’s Winter 2022 backing, and an active company now operating as InferEdge. The official site also refers to customers and partners from Harmoney’s fixed-income journey, but it does not disclose customer names or operating metrics. Tracxn reports annual revenue below ₹10 crore as of March 31, 2024, so the available evidence indicates early commercial traction rather than a fully scaled business; the company’s present AI product and brand transition make current revenue and customer adoption difficult to verify publicly.

Founders & Leadership

Aditya MehtaFounder
Co-Founder & CEO
Omkar GhaisasFounder
Co-Founder & COO
Amal DaniFounder
Co-Founder & CTO

Funding History

2022-04
Seed$500K

Y Combinator, Pioneer Fund, Soma Capital

2024-12
Seed$5.3M (inferred residual; round amount not disclosed)

Goldman Sachs

Recent News

2026-08
Harmoney is becoming InferEdge

Harmoney’s official website announces a transition to InferEdge, reflecting a shift toward agentic AI solutions for buy-side investment workflows. The company is also exiting its bond-trading software business to focus on the new platform.

2026-07-28product
We build the AI workflows investment firms run on

InferEdge’s pricing page describes a library of shipped buy-side capabilities, including screening, trend-finding, and portfolio monitoring, with pricing starting at $50,000.

2026-07-15
InferEdge: Agentic AI for buy-side firms

Y Combinator’s investment directory lists InferEdge as a company building agentic AI systems that operate across research, portfolio management, and risk for equity and fixed-income firms.

2026-07-04funding
Harmoney - 2026 Company Profile & Team

Tracxn’s 2026 company profile identifies Harmoney as a Mumbai-based seed-stage company and reports total funding of $5.8 million across three rounds.

2026-05-12product
Agentic Infrastructure for the buy-side

InferEdge’s product page positions the company as building autonomous AI systems for investment teams, wealth firms, and capital markets across research, portfolio management, risk, and CRM.

2026-05-10product
InferEdge opens access to MIND Email

InferEdge’s sign-up page promotes data, research, and AI tooling for capital markets and offers seven days of free access to its MIND Email product.

Active Roles

0

No active roles right now.

Get notified when they post

Business Model

InferEdge monetizes through paid enterprise software and service contracts for AI investment workflows. Its pricing materials show offerings starting at $50,000, alongside annual subscription tiers from $1,000 per year and an Agent Platform from $2,000 per year; fees are payable throughout the applicable service term.

Products

Agent Platform: a composable, auditable agent runtime for operational enterprise AIPortfolio and Risk Monitoring: continuous event ingestion, synthesis, impact scoring, and delivery across news, filings, transcripts, social, and researchSkills Library and Custom Skills: reusable buy-side capabilities for fundamentals, credit, events, portfolio analysis, and internal APIs, SQL, notebooks, or legacy tools

Tech Stack

Large language models, including OpenAI, Claude, Gemini, and bring-your-own modelsAgent runtime and orchestration for composable AI skillsModel Context Protocol (MCP) and open-standard connectorsReal-time data-ingestion pipelines with semantic deduplication and portfolio mappingCitation, evaluation, observability, audit-log, caching, and adaptive model-routing infrastructure

Competitors

AlphaSense
Hebbia
LinqAlpha
FactSet
S&P Capital IQ